FDA-backed CBD drug brings in $296 million in "incredible launch year," GW Pharma CEO says

GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) exceeded fourth-quarter estimates for Epidiolex sales, notching $108 million in revenue for the CBD drug, Latest Ratings for GWPH DateFir.....»»

"We have 28 countries now in Europe that have approved Epidyolex" to treat epilepsy seizures, GW Pharma CEO Justin Gover says......»»

Hospitals in the region have lost nearly $2 million year to date after changes to a drug discount program for safety net hospitals. Additional proposed changes could cut even more, resulting in reduced funds for community benefit programs......»»

Endocyte licensed a prostate cancer drug a year ago for an upfront payment of $12 million. Now, it’s being bought by the Swiss pharma giant Novartis for more than $2 billion......»»

Demand for healthcare giant Roche’s COVID-19 tests helped to offset a decline in the core drugs business, the company said on Wednesday, as it reported sales for the first quarter of 2021 and confirmed its outlook for the year......»»

Handset vendors are expected to launch more foldable devices with AMOLED screens this year. Global shipments of flexible AMOLED panels for foldable devices are expected to reach 12 million units in 2021. In the handset m.....»»

Dr. Diana Brainard, a 10-year veteran of Gilead Sciences Inc. who currently heads up the company's broad virology drug pipeline, will take over as CEO of a young cell therapy company backed by her soon-to-be former employer. Starting May 17, Brain.....»»

The substantial payout was only possible because the Pennsylvania-based drug distributor relied on a controversial accounting method: excluding legal settlement costs from its year-end CEO evaluation......»»

The substantial payout was only possible because the Pennsylvania-based drug distributor relied on a controversial accounting method: excluding legal settlement costs from its year-end CEO evaluation......»»

Lime plans to launch its shared electric bike service in 25 more cities this year. Lime's new bike will have a more powerful motor and a battery that's interchangeable with Lime's scooters. Matt Reamer/Lime Mobility startup L.....»»

Consulting giant McKinsey & Co. has reached a $573 million settlement with states over its work advising OxyContin maker Purdue Pharma LP and other drug manufacturers to aggressively market opioid painkillers, according to people familiar with the matter......»»

59 SPACs have filed for an IPO so far this year, compared to 248 SPACs going public in 2020, according to data from SPACinsider.com. .....»»

Oatly recorded $200 million in sales in 2019, and expected to double that figure to $400 million in 2020 and become profitable by 2021, a report said. Hollis Johnson/INSIDER Oatly, the popular alternative milk company that's backed by Opra.....»»

Zealand Pharma files New Drug Application with U.S. FDA for dasiglucagon HypoPal® rescue pen, secures DKK 137 million in additional investment, and .....»»

A Triangle drug company on the verge of a commercial launch is also bringing in big money to study its potential coronavirus treatment......»»

Airline SAS said on Tuesday it had signed a 3.3 billion Swedish crown ($336 million) three-year revolving credit facility agreement, 90% guaranteed by Sweden and Denmark's governments, as it looked to beat a path through the coronavirus crisis......»»

Gilead Sciences Inc. reported better-than-expected earnings for the first quarter of the year on Thursday and detailed more of its work on remdesivir, an antiviral COVID-19 drug candidate......»»

Gilead Sciences Inc. reported better-than-expected earnings for the first quarter of the year on Thursday and detailed more of its work on remdesivir, an antiviral COVID-19 drug candidate......»»

Baltimore biotechnology startup LifeSprout has closed a $28.5 million round of Series A financing, and is pursuing plans to launch clinical trials later this year. The new round was led by San Francisco's Redmile Group LLC, with participation fr.....»»

Shkreli, who became infamous for dramatically hiking the price of a life-saving drug, is serving a seven-year prison sentence for a securities fraud conviction......»»